The Turkey digital health market is anticipated to reach USD 3.05 billion by 2030 and is anticipated to expand at a CAGR of 15.8% during the forecast period, according to a new report by Grand View Research, Inc. The increasing demand for personalized medicine and rising healthcare expenses are some of the factors contributing to the market growth in Turkey. According to the Health Expenditure 2020 estimate from the Turkish Statistics Institute, healthcare expenditure in the country increased by 24.3% resulting in an investment worth USD 2.4 billion in healthcare infrastructure in 2020.
The Turkey digital health industry is gaining momentum due to the growing awareness of the benefits of digital healthcare, the availability of virtual care, advancements in healthcare IT infrastructure, chronic disease prevalence, and the demand for remote patient monitoring services. The shift towards remote healthcare is expected to boost the market growth, with wearable devices such as fitness trackers and smartwatches enabling personalized care. Advanced wearable devices and integrated analytics are transforming the market, empowering tailored digital experiences and optimizing resources and time for better services.
In February 2022, the Ministry of Health published a Regulation on the Provision of Remote Healthcare Services, limiting the services and institutions that can provide remote operations permits, with non-compliance potentially leading to service termination or withdrawal of operation permits.MoH has also developed a bilingual electronic health information system called e-Nab?z or e-Pulse, which collects hospital records and shares them with doctors and patients.
Request a free sample copy or view report summary: Turkey Digital Health Market Report
Based on technology, the telehealthcare segment dominated the market with a revenue share of over 40% in 2023 owing to the rising adoption of these services and their prominent applications in diabetes patients for remote monitoring
Based on component, the services segment accounted for the largest market revenue share in 2023 pertaining to the increased adoption of digital healthcare platforms amongst the healthcare providers
Based on applications, the diabetes segment dominated the market with the largest share in 2023. The increasing prevalence of diabetes has led to a surge in demand for preventive strategies and early intervention methods.
Some of the market players operating in the market include Samsung; Epic Systems Corporation; Medtronic; IBM Corporation; Microsoft Corporation; Oracle Cerner; Philips; Qualcomm Technologies, Inc.; GE Healthcare; Apple Inc.; among others.
Grand View Research has segmented the Turkey digital health market based on technology, component, application, and end use:
Turkey Digital Health Technology Outlook (Revenue, USD Billion, 2018 - 2030)
Tele-Healthcare
Tele-care
Activity monitoring
Remote medication management
Tele-health
LTC monitoring
Video consultation
mHealth
Wearables
BP Monitors
Glucose Meters
Pulse Oximeters
Sleep Apnea Monitors
Neurological Monitors
Activity Trackers/Actigraphs
mHealth Apps
Medical Apps
Fitness Apps
Services
mHealth Service, By Type
Monitoring Services
Independent Aging Solutions
Chronic Disease Management & Post-Acute Care Services
Diagnosis Services
Healthcare Systems Strengthening Services
Others
mHealth Services, By Participants
Mobile Operators
Device Vendors
Content Players
Healthcare Providers
Healthcare Analytics
Digital Health Systems
EHR
E-prescribing systems
Turkey Digital Health Component Outlook (Revenue, USD Billion, 2018 - 2030)
Hardware
Software
Services
Turkey Digital Health Application Outlook (Revenue, USD Billion, 2018 - 2030)
Obesity
Diabetes
Cardiovascular
Respiratory Diseases
Others
Turkey Digital Health End Use Outlook (Revenue, USD Billion, 2018 - 2030)
Patients
Providers
Players
Others
List of Key Players of Turkey Digital Health Market
Samsung
Epic Systems Corporation
Medtronic
IBM Corporation
Microsoft Corporation
Oracle Cerner
Philips
Qualcomm Technologies, Inc.
GE Healthcare
Apple Inc.
"The quality of research they have done for us has been excellent..."